Zhang L, Liu B
Institute of Biochemistry and Molecular Biology, Department of Biochemistry.
Hua Xi Yi Ke Da Xue Xue Bao. 1991 Jun;22(2):120-3.
Effects of purified human apolipoproteins AI, CI, CII, CIII-1, Cs and E on the binding of 125I-labeled apo E-deficient HDL3 to isolated rat liver plasma membranes were investigated. Unlabeled apo AI, CI, CII, CIII-1 and apo Cs, but not apo E, could effectively inhibit 125I-labeled HDL3 binding to liver membranes, apoCIII-1, was the strongest among the apoC subclasses and the inhibition curve of apoCIII-1 was similar to that of apo AI. This result indicates that apo C, especially apo CIII, may be another specific ligand of HDL receptor, and it plays an important role in regulation of HDL receptor activity in liver.
研究了纯化的人载脂蛋白AI、CI、CII、CIII-1、Cs和E对125I标记的载脂蛋白E缺陷型HDL3与分离的大鼠肝细胞膜结合的影响。未标记的载脂蛋白AI、CI、CII、CIII-1和载脂蛋白Cs,但不是载脂蛋白E,能有效抑制125I标记的HDL3与肝细胞膜的结合,载脂蛋白CIII-1在载脂蛋白C亚类中作用最强,其抑制曲线与载脂蛋白AI相似。这一结果表明,载脂蛋白C,尤其是载脂蛋白CIII,可能是HDL受体的另一种特异性配体,并且在肝脏中HDL受体活性的调节中发挥重要作用。